Fam-trastuzumab deruxtecan and Constipation: What Users Say
Brand names: Enhertu
Reviews for Fam-trastuzumab deruxtecan
- Ano...
- Taken for 1 to 6 months
- April 3, 2025
For Breast Cancer, Metastatic "Had done #6 cycle and dosage had reduced to 80% after the 2nd infusion due to liver dysfunction. The side effects are bowel system haywire, nausea, constipation, diarrhea, skin rashes, body heat, hair loss, and so on. The side effects are not getting better after each cycle. So helpless!!!!"
- Ano...
- Taken for 1 to 6 months
- April 3, 2025
For Breast Cancer, Metastatic "Had done #6 cycle and dosage had reduced to 80% after the 2nd infusion due to liver dysfunction. The side effects are bowel system haywire, nausea, constipation, diarrhea, skin rashes, body heat, hair loss, and so on. The side effects are not getting better after each cycle. So helpless!!!!"
Frequently asked questions
- How well does Enhertu work in metastatic breast cancer?
- Is Enhertu a chemotherapy drug? What's Enhertu used for?
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Tafinlar
Tafinlar is a prescription medicine used to treat BRAF mutated melanoma, non-small cell lung ...
Mekinist
Mekinist is used to treat melanoma, non-small cell lung cancer, thyroid cancer, solid tumors, and ...
Are you taking this medicine?
Your review helps others make informed decisions.More about fam-trastuzumab deruxtecan
- fam-trastuzumab deruxtecan consumer information
- Check interactions
- Compare alternatives
- Reviews (36)
- Side effects
- Dosage information
- During pregnancy
- Drug class: HER2 inhibitors
- En español
For Breast Cancer, Metastatic "Was told with LMD I had 3-6 months to live. Been on Enhertu for 10 months. One treatment every 21 days. I get Emend and steroids with the infusion. These stop the side effects. I have not had any nausea or vomiting, but have had some constipation and sometimes diarrhea. It's been the easiest of all the meds I've tried. It seems to be working systemically, my LMD has been stable, no progression so far. Grateful to have something that is finally working."